about
Opioid agonist treatment for pharmaceutical opioid dependent peopleOpioid agonist treatment for pharmaceutical opioid dependent peoplePharmacological treatment for depression during opioid agonist treatment for opioid dependenceA multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials NetworkThe effect of race on provider decisions to test for illicit drug use in the peripartum settingHeroin-assisted treatment (HAT) a decade later: a brief update on science and politicsA scoping review of home-produced heroin and amphetamine-type stimulant substitutes: implications for prevention, treatment, and policyAddiction treatment and stable housing among a cohort of injection drug usersAgent-Based Model Forecasts Aging of the Population of People Who Inject Drugs in Metropolitan Chicago and Changing Prevalence of Hepatitis C InfectionsSurvival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatmentUnobserved versus observed office buprenorphine/naloxone induction: a pilot randomized clinical trialFunctional changes of the reward system underlie blunted response to social gaze in cocaine users.Toward empirical identification of a clinically meaningful indicator of treatment outcome: features of candidate indicators and evaluation of sensitivity to treatment effects and relationship to one year follow up cocaine use outcomes.Using administrative data for longitudinal substance abuse research.Exploring the focus and experiences of smartphone applications for addiction recovery.The Edinburgh Addiction Cohort: recruitment and follow-up of a primary care based sample of injection drug users and non drug-injecting controlsManaging addiction as a chronic condition.A randomized clinical trial of methadone maintenance for prisoners: results at 12 months postrelease.Pharmacological maintenance treatments of opiate addiction.Attitudes toward buprenorphine and methadone among opioid-dependent individuals.Comparing the dynamic course of heroin, cocaine, and methamphetamine use over 10 years.Contrasting trajectories of heroin, cocaine, and methamphetamine use.Race/ethnicity and geographic access to Medicaid substance use disorder treatment facilities in the United States.Accounting for individual differences and timing of events: estimating the effect of treatment on criminal convictions in heroin users.Structural Ecosystems Therapy for HIV+ African-American women and drug abuse relapseIncarceration and opioid withdrawal: the experiences of methadone patients and out-of-treatment heroin users.Preventing death among the recently incarcerated: an argument for naloxone prescription before release.Characterizing longitudinal health state transitions among heroin, cocaine, and methamphetamine users.Factors affecting willingness to provide buprenorphine treatment.The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence.Understanding prolonged cessation from heroin use: findings from a community-based sample.Perceived neighborhood safety, recovery capital, and successful outcomes among mothers 10 years after substance abuse treatmentWhy is alcohol excluded and opium included in NDPS act, 1985?Modeling the impact of simulated educational interventions on the use and abuse of pharmaceutical opioids in the United States: a report on initial efforts.Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.The therapeutic workplace to promote treatment engagement and drug abstinence in out-of-treatment injection drug users: a randomized controlled trial.Offending, custody and opioid substitution therapy treatment utilisation among opioid-dependent people in contact with the criminal justice system: comparison of Indigenous and non-Indigenous AustraliansDifferences in Mortality among Heroin, Cocaine, and Methamphetamine Users: A Hierarchical Bayesian ApproachInvestigating the effects of San Francisco's Treatment on Demand Initiative on a publicly-funded substance abuse treatment system: a time series analysis.Predictors of social anxiety in an opioid dependent sample and a control sample.
P2860
Q24185775-4754B990-FB82-4EFD-8FA0-37CEBFD4D824Q24194813-5ABE0C7E-4EAF-4AA1-802D-04C2E559F179Q24235458-FBD93DFE-F3F8-4EC9-913C-748853CE947FQ24548339-71319A75-F385-4076-BE86-5DC0BE5BCBDBQ24633100-BB64907B-217F-4475-B135-B8C2E701275CQ24643474-C69FEA56-FB91-4EA4-91F8-E2BFE2B42603Q26752324-EE23D32E-1F48-4105-9D2F-08FF489927B3Q28474879-AFA43FC8-87C2-437B-BDCD-853EA5A7682CQ28548643-499EDE94-6586-4CC7-8909-B1CC345F02BFQ28750627-6BC44E63-A460-4B85-AF20-D0FBF6DA05FBQ30432435-88FBCCBB-A6FB-4B06-BB46-D3513F833D71Q30572554-F009E2E2-52E7-4F38-814A-069E72392D42Q30579736-242356AE-99E4-4653-B21C-FF7A02139E03Q31168666-A3D38A78-6C96-4D2C-8186-948600A4102AQ33440067-62AEE749-A40A-46EB-BF91-D97AF9620D79Q33534850-C525B2BA-D225-4365-9E29-1AD0D4560547Q33553127-98F1101B-A7CC-445E-9313-DFF93FB4D98EQ33578730-3E68AF20-B52B-4373-80C7-EC70D7E35E31Q33582080-34B95635-428D-4A04-820E-3BC907FB795EQ33621921-9C71E38C-4930-49CD-8DC7-1965ACD5F5E7Q33641858-2CBEBC68-5D12-4F20-8713-39399A4AAC18Q33651986-8A6B23EE-CB65-4E9B-90C4-77D09BEEB008Q33690135-6B85E91B-4206-4703-9437-1630E2E3088CQ33693992-FD702AC1-624A-41D1-8EF4-57ECE63C2B0CQ33720877-966C4AD6-A493-43E7-9458-04ACC42A7D36Q33727237-A5D78160-A1DB-4B1B-8ACA-9BEC97BB50A0Q33775772-03F75C0B-F206-4750-AC57-38977294108CQ33810775-C56DDF93-D928-4B23-8332-BFE54A78AF6CQ33836333-CED07CA3-E854-48BC-B233-DA1386140C63Q33870389-939DB72F-649F-4197-8DC1-9D0571D89940Q33956645-122D2BB0-B9C8-49E8-A1C4-BD723EFC6908Q33976597-1AD58B7C-1907-477A-A768-A533BBF24BFDQ34048335-22ED2F4A-6A32-4F68-A2E5-E19458FDF30AQ34060098-B2B0C655-5828-4960-8485-841971A167DDQ34081656-4C59317F-CF00-4765-8BD1-D27A980081C7Q34135584-0297963A-4DBD-4D36-BDDD-2F6EDED2A7EAQ34207684-34502592-F587-448C-BE57-F435D1230FEEQ34255829-30127B81-3763-4D4B-8D03-43039F8B4A54Q34335198-A4AA812A-A920-4EC3-8F86-AE0FF5C2A0BFQ34401736-F5A0BCBB-65D3-46ED-9D61-099B57DA6C99
P2860
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
A 33-year follow-up of narcotics addicts.
@en
A 33-year follow-up of narcotics addicts.
@nl
type
label
A 33-year follow-up of narcotics addicts.
@en
A 33-year follow-up of narcotics addicts.
@nl
prefLabel
A 33-year follow-up of narcotics addicts.
@en
A 33-year follow-up of narcotics addicts.
@nl
P2093
P1433
P1476
A 33-year follow-up of narcotics addicts.
@en
P2093
P304
P356
10.1001/ARCHPSYC.58.5.503
P407
P577
2001-05-01T00:00:00Z